Advanced search
Publication Cover
Gynecological Endocrinology Volume 39, 2023 - Issue 1
Submit an article Journal homepage
1,497
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Optimal timing to retrieve oocytes for fertility preservation in patients with acute myeloid leukemia: two cases of controlled ovarian stimulation using DuoStim with a literature review

Mami Sekiguchia Department of Obstetrics and Gynecology, Faculty of Medicine, Toho University, Tokyo, Japan;b Department of Obstetrics and Gynecology, Toho University Omori Medical Center, Tokyo, Japan;c Reproduction Center, Toho University Omori Medical Center, Tokyo, JapanView further author information
,
Ayumu Itoa Department of Obstetrics and Gynecology, Faculty of Medicine, Toho University, Tokyo, Japan;b Department of Obstetrics and Gynecology, Toho University Omori Medical Center, Tokyo, Japan;c Reproduction Center, Toho University Omori Medical Center, Tokyo, JapanView further author information
,
Yusuke Fukudaa Department of Obstetrics and Gynecology, Faculty of Medicine, Toho University, Tokyo, Japan;b Department of Obstetrics and Gynecology, Toho University Omori Medical Center, Tokyo, Japan;c Reproduction Center, Toho University Omori Medical Center, Tokyo, JapanView further author information
,
Masato Yoneyamaa Department of Obstetrics and Gynecology, Faculty of Medicine, Toho University, Tokyo, Japan;b Department of Obstetrics and Gynecology, Toho University Omori Medical Center, Tokyo, Japan;c Reproduction Center, Toho University Omori Medical Center, Tokyo, JapanView further author information
,
Mayuko Furuia Department of Obstetrics and Gynecology, Faculty of Medicine, Toho University, Tokyo, Japan;b Department of Obstetrics and Gynecology, Toho University Omori Medical Center, Tokyo, Japan;c Reproduction Center, Toho University Omori Medical Center, Tokyo, JapanView further author information
,
Kentaro Nakaokaa Department of Obstetrics and Gynecology, Faculty of Medicine, Toho University, Tokyo, Japan;b Department of Obstetrics and Gynecology, Toho University Omori Medical Center, Tokyo, Japan;c Reproduction Center, Toho University Omori Medical Center, Tokyo, JapanView further author information
,
Nahomi Umemuraa Department of Obstetrics and Gynecology, Faculty of Medicine, Toho University, Tokyo, Japan;b Department of Obstetrics and Gynecology, Toho University Omori Medical Center, Tokyo, Japan;c Reproduction Center, Toho University Omori Medical Center, Tokyo, JapanView further author information
,
Yuko Hayashia Department of Obstetrics and Gynecology, Faculty of Medicine, Toho University, Tokyo, Japan;b Department of Obstetrics and Gynecology, Toho University Omori Medical Center, Tokyo, Japan;c Reproduction Center, Toho University Omori Medical Center, Tokyo, JapanView further author information
,
Yuko Tamakia Department of Obstetrics and Gynecology, Faculty of Medicine, Toho University, Tokyo, Japan;b Department of Obstetrics and Gynecology, Toho University Omori Medical Center, Tokyo, Japan;c Reproduction Center, Toho University Omori Medical Center, Tokyo, JapanView further author information
,
Yukiko Katagiria Department of Obstetrics and Gynecology, Faculty of Medicine, Toho University, Tokyo, Japan;b Department of Obstetrics and Gynecology, Toho University Omori Medical Center, Tokyo, Japan;c Reproduction Center, Toho University Omori Medical Center, Tokyo, JapanCorrespondence[email protected]
View further author information
&
Masahiko Nakataa Department of Obstetrics and Gynecology, Faculty of Medicine, Toho University, Tokyo, Japan;b Department of Obstetrics and Gynecology, Toho University Omori Medical Center, Tokyo, JapanView further author information
 show all
Article: 2217262 | Received 27 Sep 2022, Accepted 18 May 2023, Published online: 04 Jun 2023

Figures & data

Figure 1. Time course of ovarian stimulation and oocyte retrieval in (A) Case 1 and (B) Case. OR, oocyte retrieval; DYG, dydrogesterone; human menopausal gonadotrophin; uhCG, urine human chorionic gonadotropin; rechCG, recombinant human chorionic gonadotropin;.

Figure 1. Time course of ovarian stimulation and oocyte retrieval in (A) Case 1 and (B) Case. OR, oocyte retrieval; DYG, dydrogesterone; human menopausal gonadotrophin; uhCG, urine human chorionic gonadotropin; rechCG, recombinant human chorionic gonadotropin;.

Table 1. Previously reported cases of controlled ovarian stimulation for fertility preservation in patients with acute myeloid leukemia.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.